Supplements
Urolithin A Supplement: Benefits, Dosage, and What the Research Actually Shows
Urolithin A is quietly becoming one of the most compelling longevity compounds in clinical research — yet most people have never heard of it. Derived from gut-bacteria metabolism of pomegranate and berry polyphenols, this postbiotic activates mitophagy, the cellular process that clears out damaged mitochondria. If you've been searching for a supplement that targets aging at the cellular level, here's what the evidence actually says.
What Is Urolithin A and Why Is It Getting Attention?
Urolithin A (UA) is a naturally occurring compound produced when gut bacteria metabolize ellagitannins — polyphenols found in pomegranates, walnuts, and certain berries. The catch: less than 40% of people produce meaningful amounts of urolithin A from food alone, because the conversion depends entirely on specific gut microbiome compositions (Selma et al., Food & Function 2014; PMID: 24630939). This biological inequality is exactly why a direct urolithin A supplement has become so relevant.
Urolithin A's primary mechanism is the activation of mitophagy — the selective autophagy pathway that removes damaged, dysfunctional mitochondria and allows healthy new ones to form. As mitochondria accumulate damage with age, cellular energy production declines, contributing to muscle weakness, fatigue, and reduced physical resilience. By upregulating mitophagy, urolithin A effectively acts as a cellular recycling program for your energy infrastructure.
This isn't theoretical. The compound has moved from petri dishes to randomized human trials, with results showing measurable improvements in muscle endurance, mitochondrial biomarkers, and inflammatory profiles. Let's break down exactly what the research shows — and what it doesn't.
---
The Clinical Evidence for Urolithin A Supplementation
The landmark human trial came from Amazentis (the team behind the MitoPrime/Timeline Urolithin A compound) and was published in Nature Metabolism in 2019. In a randomized, double-blind, placebo-controlled trial of 60 sedentary older adults (average age 71), participants receiving 1,000 mg/day of urolithin A for four months showed statistically significant improvements in muscle endurance — specifically, a 12% increase in hand grip strength endurance and meaningful improvements in walking distance — compared to placebo (Andreux et al., Nature Metabolism 2019; PMID: 31384085). Critically, the urolithin A group also showed elevated mitochondrial gene expression and reduced plasma levels of inflammatory acylcarnitines, confirming the mitophagy mechanism was active in humans, not just in animal models.
A follow-up 2022 trial in JAMA Network Open enrolled 88 healthy middle-aged adults and found that 500 mg/day and 1,000 mg/day of urolithin A for four months both significantly improved muscle strength and aerobic endurance, with the 1,000 mg dose producing larger effects on VO₂ max-related markers (Liu et al., JAMA Network Open 2022; PMID: 35476077). Safety profiles were excellent at both doses, with no serious adverse events reported.
Beyond muscle health, preclinical and early clinical evidence points to urolithin A's potential in:
- Gut barrier integrity: Animal models suggest UA strengthens tight junctions and reduces intestinal permeability (Singh et al., Nature Communications 2022; doi.org/10.1038/s41467-022-29979-5)
- Neurological health: Murine models of Alzheimer's show reduced amyloid-beta accumulation and improved cognitive markers after UA supplementation (Gong et al., Acta Pharmaceutica Sinica B 2019; PMID: 31909038), though human neurological trials are still in early phases
- Inflammation reduction: UA inhibits NF-κB signaling pathways, a key driver of systemic low-grade inflammation associated with metabolic aging (Zhao et al., Nutrients 2021; doi.org/10.3390/nu13020399)
---
Urolithin A Dosage: What Clinical Trials Actually Used
One of the most common questions is simply: how much urolithin A should you take? Here's a breakdown of doses used across key trials:
| Study | Population | Dose | Duration | Key Outcome |
|---|---|---|---|---|
| Andreux et al. 2019 (*Nature Metabolism*) | Sedentary adults 65–90 | 1,000 mg/day | 4 months | ↑ muscle endurance, ↓ inflammatory acylcarnitines |
| Liu et al. 2022 (*JAMA Network Open*) | Healthy adults 40–65 | 500–1,000 mg/day | 4 months | ↑ muscle strength, ↑ aerobic capacity markers |
| Amazentis Phase 1 Safety (2019) | Healthy adults 18–65 | 250–2,000 mg/day | 4 weeks | Safe and well-tolerated across all doses |
The consensus from these trials places the effective clinical dose at 500–1,000 mg/day, with 1,000 mg appearing to be the dose associated with more robust mitochondrial biomarker improvements. There is no strong evidence that doses above 1,000 mg provide additional benefit, and the compound is lipophilic, meaning absorption is improved when taken with a fat-containing meal.
It's also worth noting that urolithin A supplements are most commonly available in two forms: pure urolithin A powder/capsules (often standardized from pomegranate extract fermentation) and Timeline Nutrition's MitoPure, which is the proprietary crystalline UA used in the published trials. If you're comparing products, ensure the formulation used actual urolithin A rather than just pomegranate extract — the latter requires your gut bacteria to do the conversion, which, as noted, a significant portion of the population cannot reliably perform.
---
Who Benefits Most from a Urolithin A Supplement?
Not everyone needs a urolithin A supplement at the same priority level. Based on the mechanistic and clinical literature, the people likely to see the most meaningful benefit are:
- Adults over 40 experiencing declining exercise capacity or muscle fatigue — mitochondrial density naturally declines with age, and UA directly addresses this pathway
- Individuals with poor microbiome diversity — if you're not converting dietary ellagitannins due to gut composition, supplemental UA bypasses the conversion bottleneck entirely
- People with elevated inflammatory markers (CRP, IL-6) — UA's NF-κB inhibition may complement other anti-inflammatory protocols
- Those focused on longevity optimization — UA is one of a small number of compounds with direct evidence of mitophagy activation in humans, alongside clinical evidence for NMN supplementation and caloric restriction mimetics
- Athletes seeking recovery support — emerging evidence suggests UA's mitochondrial renewal effects may reduce exercise-induced mitochondrial damage
Younger adults with diverse diets rich in pomegranate, raspberries, and walnuts may already produce adequate urolithin A endogenously — though testing this definitively requires microbiome metabolomics, the kind of analysis increasingly available through platforms that integrate lab data.
---
Heart Health Supplement Context: Where Urolithin A Fits
Urolithin A is gaining relevance in the heart health supplement space, though it's best understood as a complementary tool rather than a standalone cardiac intervention. The mitophagy mechanism matters here: cardiomyocytes (heart muscle cells) are among the most mitochondria-dense cells in the body, and mitochondrial dysfunction is a recognized driver of both heart failure and age-related cardiac decline (Bhatt et al., Journal of Molecular and Cellular Cardiology 2017; PMID: 28365258).
In preclinical models, urolithin A has shown cardioprotective effects by reducing oxidative stress in cardiac tissue and improving mitochondrial biogenesis in heart cells (Jayarathne et al., Molecular Nutrition & Food Research 2021; doi.org/10.1002/mnfr.202100264). Human cardiac trials are not yet published, but the mechanistic case is compelling enough that UA is increasingly stacked alongside established heart health compounds like CoQ10/Ubiquinol and Omega-3 (EPA/DHA) in longevity-focused protocols.
For comprehensive heart support, Ones includes a dedicated Heart Support System Blend that combines established cardiac ingredients. The Ones platform analyzes wearable data (resting heart rate, HRV trends) alongside biomarkers like lipid panels and CRP to calibrate which cardiac-adjacent compounds belong in your formula at clinically meaningful doses.
If you're building out a complete cardiovascular protocol, understanding the omega-3 EPA DHA ratio guide and how it interacts with mitochondrial health compounds is a useful starting point.
---
Magnesium L-Threonate Supplement: A Relevant Cognitive Stack Partner
When discussing mitochondrial health and aging, magnesium l-threonate consistently comes up as a complementary ingredient — and for good reason. Unlike magnesium glycinate or magnesium citrate, l-threonate is the only form of magnesium clinically demonstrated to cross the blood-brain barrier and raise cerebrospinal fluid magnesium levels (Slutsky et al., Neuron 2010; PMID: 20152124).
In a randomized, double-blind trial of 44 adults aged 50–70 with suboptimal cognitive function, magnesium l-threonate (1,500–2,000 mg/day of Magtein, delivering ~144 mg elemental magnesium) significantly improved composite cognitive scores and reduced brain age by an estimated 9 years compared to placebo over 12 weeks (Liu et al., Journal of Alzheimer's Disease 2016; PMID: 27801174). This synergizes with urolithin A's emerging neuroprotective research — both compounds may support neuronal energy metabolism through complementary pathways: UA through mitophagy and mitochondrial quality control, magnesium l-threonate through synaptic plasticity and NMDA receptor modulation.
For those interested in the full science of magnesium forms and cognitive performance, the optimal magnesium glycinate dosage article covers which form to choose for sleep and relaxation vs. cognitive goals.
Ones includes both magnesium glycinate (as part of the Magnesium Complex System Blend for sleep and muscle recovery) and can incorporate magnesium l-threonate as a targeted individual ingredient in formulas calibrated for cognitive support goals.
---
Digestive Enzymes Supplement: Supporting Polyphenol Absorption
While urolithin A supplementation bypasses the gut-conversion bottleneck, the broader category of digestive enzymes supplements plays a meaningful supporting role for anyone trying to maximize polyphenol bioavailability from whole foods — and for overall absorption of fat-soluble supplements including urolithin A itself.
Research published in Nutrients (2021) has shown that proteolytic and lipase enzyme activity influences the absorption efficiency of fat-soluble bioactive compounds, including polyphenols, by improving emulsification and mucosal uptake (Bohn et al., Nutrients 2021; doi.org/10.3390/nu13030875). For individuals with compromised digestive output — which often correlates with aging, stress, or proton pump inhibitor use — supplemental digestive enzymes may meaningfully improve the net bioavailability of lipophilic compounds like urolithin A.
This is particularly relevant because urolithin A's phase 1 trial data showed dose-dependent plasma absorption — meaning optimizing gut conditions could influence how much of a supplement actually reaches systemic circulation.
---
What This Means for Your Ones Formula
Ones is designed to move beyond generic supplement stacks by analyzing your actual health data — including blood work, wearable metrics, and health history — to build a personalized formula from 70+ clinical-grade ingredients.
For urolithin A and mitochondrial health specifically, here's how Ones approaches the evidence:
Urolithin A (500–1,000 mg): Dosed to match the range used in the Andreux 2019 and Liu 2022 trials, and included based on indicators like age, activity levels, muscle fatigue patterns from wearable data, and inflammatory marker trends from bloodwork.
CoQ10/Ubiquinol (200 mg): Ones includes ubiquinol — the reduced, more bioavailable form — at 200 mg, matching the dose range used in heart failure and mitochondrial dysfunction trials (Mortensen et al., JACC: Heart Failure 2014; PMID: 24698985). CoQ10 and urolithin A target overlapping but distinct mitochondrial pathways, making them a logical pairing in mitochondrial support formulas.
Omega-3 (EPA/DHA): Ones incorporates pharmaceutical-grade omega-3 at clinically relevant EPA/DHA doses, calibrated to your actual lipid panel results. Omega-3s reduce mitochondrial oxidative stress and complement UA's anti-inflammatory NF-κB inhibition. If you're curious about the evidence base, exploring the clinical evidence for ashwagandha alongside adaptogens in stress-mitochondria crosstalk is another relevant read.
Formulas come in 6, 9, or 12-capsule plans, so the addition of urolithin A is always calibrated against your full ingredient budget — you'll never get a redundant or sub-therapeutic stack.
---
Key Takeaways
- Urolithin A activates mitophagy — the cellular process of clearing damaged mitochondria — and is one of the few compounds with direct human trial evidence for this mechanism
- Clinical doses range from 500–1,000 mg/day, with the 1,000 mg dose showing stronger mitochondrial biomarker improvements in the 2019 Nature Metabolism trial (n=60, 4 months)
- Less than 40% of adults produce meaningful urolithin A from food, making direct supplementation necessary for the majority of the population
- Urolithin A pairs well with CoQ10/Ubiquinol, Omega-3, and magnesium l-threonate for comprehensive mitochondrial and cognitive aging support
- Heart health relevance is emerging — preclinical data supports cardioprotective effects through mitochondrial quality control in cardiomyocytes, though human cardiac trials are still pending
- Ones personalizes urolithin A dosing based on your bloodwork, wearable data, and health goals, stacking it alongside complementary mitochondrial ingredients like CoQ10 Ubiquinol at 200 mg and pharmaceutical-grade Omega-3 within your capsule budget
Always consult a qualified healthcare provider before starting any new supplement protocol, particularly if you have existing medical conditions or take prescription medications.